Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Progesterone Receptor Antibody [PR501] | Login | Progesterone Receptor Antibody [PR501] | ||||||||||||||||
|
||||||||||||||||||
| Podocalyxin Antibody [3D3] | Login | Podocalyxin Antibody [3D3] | ||||||||||||||||
|
||||||||||||||||||
| Prolactin Receptor Antibody [PRLR742] | Login | Prolactin Receptor Antibody [PRLR742] | ||||||||||||||||
|
||||||||||||||||||
| CD45RO Antibody [UCHL-1] | Login | CD45RO Antibody [UCHL-1] | ||||||||||||||||
|
||||||||||||||||||
| CD45RA Antibody [158-4D3] | Login | CD45RA Antibody [158-4D3] | ||||||||||||||||
|
||||||||||||||||||
| CD45RB Antibody [PD7/26] | Login | CD45RB Antibody [PD7/26] | ||||||||||||||||
|
||||||||||||||||||
| CD45RB Antibody [BRA-11] | Login | CD45RB Antibody [BRA-11] | ||||||||||||||||
|
||||||||||||||||||
| RBP Antibody [G4E4] | Login | RBP Antibody [G4E4] | ||||||||||||||||
|
||||||||||||||||||
| gp100 Antibody [HMB45] | Login | gp100 Antibody [HMB45] | ||||||||||||||||
|
||||||||||||||||||
| Melanoma Antibody [NKI-beteb] | Login | Melanoma Antibody [NKI-beteb] | ||||||||||||||||
|
||||||||||||||||||
| SLC3A2 Antibody [UM7F8] | Login | SLC3A2 Antibody [UM7F8] | ||||||||||||||||
|
||||||||||||||||||
| SUMO 2/3 Antibody [SM23/496] | Login | SUMO 2/3 Antibody [SM23/496] | ||||||||||||||||
|
||||||||||||||||||
| CD43 Antibody [DF-T1] | Login | CD43 Antibody [DF-T1] | ||||||||||||||||
|
||||||||||||||||||
| Estrogen Inducible Protein pS2 Antibody [GE2] | Login | Estrogen Inducible Protein pS2 Antibody [GE2] | ||||||||||||||||
|
||||||||||||||||||
| Transferrin Receptor Antibody [DF1513] | Login | Transferrin Receptor Antibody [DF1513] | ||||||||||||||||
|
||||||||||||||||||
| Transferrin Receptor Antibody [66IG10] | Login | Transferrin Receptor Antibody [66IG10] | ||||||||||||||||
|
||||||||||||||||||
| Thyroglobulin Antibody [2H11 or TGB04] | Login | Thyroglobulin Antibody [2H11 or TGB04] | ||||||||||||||||
|
||||||||||||||||||
| Thyroglobulin Antibody [6E1 or TGB05] | Login | Thyroglobulin Antibody [6E1 or TGB05] | ||||||||||||||||
|
||||||||||||||||||
| TGF alpha Antibody [MF9] | Login | TGF alpha Antibody [MF9] | ||||||||||||||||
|
||||||||||||||||||
| TGF alpha Antibody [1E8-G6] | Login | TGF alpha Antibody [1E8-G6] | ||||||||||||||||
|
||||||||||||||||||
| TTF-1 Antibody [8G7G3/1] | Login | TTF-1 Antibody [8G7G3/1] | ||||||||||||||||
|
||||||||||||||||||
| IRAK4 Antibody | Login | IRAK4 Antibody | ||||||||||||||||
|
||||||||||||||||||
| ZIC3 Antibody | Login | ZIC3 Antibody | ||||||||||||||||
|
||||||||||||||||||
| DSG2 Antibody | Login | DSG2 Antibody | ||||||||||||||||
|
||||||||||||||||||
| OAS3 Antibody | Login | OAS3 Antibody | ||||||||||||||||
|
||||||||||||||||||


